UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition Rectogesic4mggrektalsalva-SE-PLC-MPD
identifier: http://ema.europa.eu/fhir/mpId
/SE-100011473-00022988, http://ema.europa.eu/fhir/eurdId
/1552
domain: Human use
status: Current
combinedPharmaceuticalDoseForm: Rectal ointment
indication:
Rectogesic 4 mg/g rektalsalva är avsett för vuxna för att lindra smärta i samband med kronisk analfissur. Vid den kliniska utvecklingen av läkemedlet har en måttlig effekt visats beträffande lindring av medelintensiteten av daglig smärta (se avsnitt Farmakodynamik).
legalStatusOfSupply: Medicinal product subject to medical prescription
classification: glyceryl trinitrate
name
productName: Rectogesic 4 mg/g rektalsalva
part
part: Rectogesic
type: Invented name part
part
part: 4 mg
type: Strength part
part
part: rektalsalva
type: Pharmaceutical dose form part
Usages
Country Language Kingdom of Sweden Swedish